Zurück zu Projekte

12948.1;9 PFLS-LS

Synthetic Biology for the Discovery of Novel 11 B-HSD Inhibitors

Zusammenfassung

Synthetic Biology for the Discovery of Novel 11 B-HSD Inhibitors

Weitere Texte

Abstract

The enzyme 11â-hydroxysteroid dehydrogenase type 1 (11â-HSD1) acts as a cellular switch to mediate glucocorticoid action. Excessive cortisol production through 11â-HSD1 has been implicated in several diseases like metabolic syndrome, type II diabetes, obesity and skin aging. This project aims at the discovery of novel specific inhibitors of 11â-HSD1 using Evolva¿s Synthetic Biology Technology Platform. Alongside we will improve this technology in several aspects that will allow us to rebuild unknown biosynthetic pathways in yeast and efficiently identify and produce bioactive compounds for the healthcare industry.

Beteiligte

Eric Kübler

Kontaktperson

eric.kuebler@fhnw.ch

Fachhochschule Nordwestschweiz Eric Kübler Gründenstr. 40 4132 Muttenz BL CH

Projektdetails

Forschungsstelle
INNOSUISSE
Projektstatus
Abgeschlossen
Projekttyp
Forschungsprojekt
Startdatum
2012-01-31
Enddatum
2015-11-30
Bewilligte Gesamtkosten
CHF 377920.00
Sektion
20 Förderbereich Life Sciences
NABS Politikbereich
Nicht aufteilbare / nicht zuteilbare Forschung

Forschungsdisziplinen

  • T490 Biotechnology 100.0%